CF
WGS icon

Corebridge Financial’s GeneDx Holdings WGS Stock Holding History

Corebridge Financial’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,258
Closed -$554K – 2783
2025
Q1 		$554K Sell
6,258
-94
-1% -$8.15K ﹤0.01% 1538
2024
Q4 		$488K Sell
6,352
-346
-5% -$24.2K ﹤0.01% 1699
2024
Q3 		$284K Buy
6,698
+156
+2% +$5.27K ﹤0.01% 2026
2024
Q2 		$171K Buy
+6,542
New +$124K ﹤0.01% 2292

Other funds holding WGS

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Corebridge Financial's WGS Position: Q2 2025 in Review

Corebridge Financial sold out of GeneDx Holdings (WGS) in Q2 2025, closing a stake of 6,258 shares — an estimated $554K sold.

Corebridge Financial first reported a position in WGS in Q2 2024 and held it in 4 quarters. The position peaked at $554K in Q1 2025. 231 funds tracked by Wall St. Rank hold WGS as of Q2 2025.

  • Corebridge Financial reported no remaining GeneDx Holdings position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 6,258 GeneDx Holdings shares in Q2 2025, an estimated $554K.
  • Corebridge Financial first reported a position in GeneDx Holdings in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's GeneDx Holdings position peaked at $554K in Q1 2025.
  • 231 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.